Colon cancer together with rectal cancer is the fourth most commonly diagnosed cancer in both men and women. Today, advances in surgery, radiation, chemotherapy agents, and targeted therapies–often offered in integrated treatments—are bringing new hope and better options to colorectal cancer patients.
Stony Brook's Colorectal Cancer Team evaluates and manages treatment of patients with colon and rectal cancers, Crohn's Disease, familial polyposis, ulcerative colitis, and other diseases of the large bowel. The team places an emphasis on early screenings, particularly in high-risk groups, and adheres to National Quality Forum guidelines for assessment of quality care. Depending on the patient's needs and preferences, the colorectal team deploys a wide range of diagnostic and treatment techniques, including pioneering, multi-therapy approaches.